Skip to main content Skip to section navigation Skip to footer

ClearPoint Neuro, Inc.

Investor Relations

  • Investors
  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • clearpointneuro.com
This website uses cookies to improve your experience. ACCEPT REJECT

Press Releases

News & Events

News & Events

  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
May 18, 2023 4:01pm EDT

ClearPoint Neuro to Present at the B. Riley Securities 2023 Institutional Investor Conference

May 11, 2023 4:05pm EDT

ClearPoint Neuro Reports First Quarter 2023 Results

May 10, 2023 4:05pm EDT

ClearPoint Neuro to Present Investigational Research and Showcase Novel Innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles

Apr 28, 2023 4:42pm EDT

ClearPoint Neuro to Announce First Quarter 2023 Results May 11, 2023

Apr 20, 2023 4:05pm EDT

ClearPoint Neuro to Showcase Two Novel Innovations at AANS 2023: ClearPoint Maestro® Brain Model and ClearPoint Prism™ Neuro Laser Therapy System

Apr 18, 2023 4:05pm EDT

ClearPoint Neuro Announces Agreement with NE Scientific to Integrate Gene Therapy Infusion Coverage Tool into ClearPoint Maestro® Brain Model

Apr 13, 2023 4:05pm EDT

ClearPoint Neuro Announces ANVISA Approval of Neuro Navigation Portfolio in Brazil

Apr 11, 2023 4:05pm EDT

ClearPoint Neuro Extends Software License and Research Agreement with Philips to Include Fully Automatic Subnuclei Segmentation for DBS

Mar 28, 2023 4:05pm EDT

ClearPoint Neuro Announces Exclusive Multi-Year Licensing Agreement with UCSF for Innovative Intra-Cerebral Cellular Delivery Platform

Mar 01, 2023 4:05pm EST

ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 35
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
ClearPoint Neuro, Inc. Youtube ClearPoint Neuro, Inc. Facebook ClearPoint Neuro, Inc. Twitter ClearPoint Neuro, Inc. LinkedIn ClearPoint Neuro, Inc. Instagram
©2025 ClearPoint Neuro, Inc. All Rights Reserved.
Privacy Policy Cookie Policy Terms of Use California Compliance Declaration Sitemap